You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 29, 2024

Investigational Drug Information for Idalopirdine

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Idalopirdine?

Idalopirdine is an investigational drug.

There have been 10 clinical trials for Idalopirdine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2014.

The most common disease conditions in clinical trials are Alzheimer Disease and [disabled in preview]. The leading clinical trial sponsors are H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., and [disabled in preview].

Recent Clinical Trials for Idalopirdine
Positron Emission Tomography (PET) Study in Patients With Alzheimer's DiseaseH. Lundbeck A/SPhase 1
Bioequivalence Study of Idalopirdine in Healthy SubjectsH. Lundbeck A/SPhase 1
Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy MenH. Lundbeck A/SPhase 1

See all Idalopirdine clinical trials

Clinical Trial Summary for Idalopirdine

Top disease conditions for Idalopirdine
Top clinical trial sponsors for Idalopirdine

See all Idalopirdine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.